Related Experiment Videos
On lowering lipids in the post-infarction patient
1Rayne Institute, St Thomas's Hospital, London, UK.
Insights
Lowering high cholesterol in coronary heart disease (CHD) patients significantly reduces recurrent events and mortality. Effective treatment of hypercholesterolemia is crucial for secondary prevention in CHD.
Area of Science:
- Cardiology
- Preventive Medicine
- Lipidology
Background:
- Elevated serum cholesterol is a significant predictor of recurrent coronary events in patients with coronary heart disease (CHD).
- The excess risk associated with high cholesterol is more pronounced in individuals with existing CHD compared to those without.
- Classical risk factors, including hypercholesterolemia, necessitate effective management strategies for secondary prevention.
Purpose of the Study:
- To review a meta-analysis of trials investigating cholesterol-lowering interventions for secondary prevention in CHD.
- To examine the mechanisms linking cholesterol reduction to improved outcomes in CHD patients.
- To provide clinical practice implications for managing hypercholesterolemia in CHD.
Main Methods:
- Meta-analysis of eight qualifying trials focused on cholesterol lowering for secondary prevention of CHD.
- Review of existing literature on the relationship between cholesterol levels and cardiovascular events.
- Analysis of trial data to assess the impact on recurrent non-fatal and fatal CHD events and overall mortality.
Main Results:
- Significant reductions observed in recurrent non-fatal and fatal coronary heart disease (CHD) events.
- A discernible downward trend in total mortality was noted across the analyzed trials.
- Cholesterol lowering demonstrated a clear benefit in the secondary prevention of cardiovascular disease.
Conclusions:
- Hypercholesterolemia should be actively identified and treated in patients diagnosed with coronary heart disease.
- Effective cholesterol management is a cornerstone of secondary prevention strategies for CHD.
- Clinical practice should prioritize the treatment of high cholesterol in CHD patients, barring contraindications.
Abstract:
In patients with coronary heart disease (CHD) elevated serum cholesterol levels, like other classical risk factors, remain predictive of further coronary events. The excess risk attributable to raised cholesterol levels is considerable, and greater than that in subjects without CHD. A recent meta-analysis of all eight qualifying trials of secondary prevention of CHD by cholesterol lowering is reviewed. There were significant reductions in recurrent non-fatal and fatal CHD, with a downward trend in total mortality. Mechanisms underlying the relationship between cholesterol lowering and secondary prevention are reviewed. The implication of this analysis of trials for clinical practice is that hypercholesterolaemia should be sought and effectively treated in patients with CHD, unless contraindications are present.